Ewing sarcoma (nine samples from eight patient), osteosarcoma (eleven samples from eight patients), rhabdomyosarcoma (eight samples from six patients) and neuroblastoma (16 samples from 13 patients) showed a low expression of CLDN6 below a value of 104. This evidence concerns the gene CLDN6 and osteosarcoma.